243879
Study Dates:
Screening will take place throughout 2021 - please call 01895 614 888 for the latest screening days and times.
Trial Number
243879
Group
● Healthy Volunteer
● Smoking (Yes)
Compensation
Up to: $5,444
Gender
Male, Female, Smoker
Age
18-55
Additional Information
This study consists of 1 screening visit, 7* nights in-house for each period, 4 outpatient visits in each period and 1 Final Follow up visit.
Volunteers must be non-smokers or light smokers (up to 5 per day only).
BMI has to be less than or equal to 29.9 kg/m2
Details
This is a 2-period study to assess the immunogenicity of 2 doses of study drug (QL0605) compared to 2 doses of US Neulasta in healthy male and female volunteers.
The study drug will
be administered in the form of a subcutaneous injection.
This is Not First In Human Study.